Atricure Inc. buy Needham & Company LLC
Start price
27.03.25
/
50%
€29.29
Target price
27.03.26
€47.37
Performance (%)
-9.18%
Price
18.02.26
€27.40
Summary
This prediction is currently active. With a performance of -9.18%, the BUY prediction by Needham___Company_LL is trending in the wrong direction. This prediction currently runs until 27.03.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -2.143% | -2.143% |
| iShares Core DAX® | 0.608% | 0.340% |
| iShares Nasdaq 100 | 0.636% | -3.172% |
| iShares Nikkei 225® | -0.128% | 8.916% |
| iShares S&P 500 | 0.544% | -0.699% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat